PerkinElmer to acquire antibodies and reagents manufacturer BioLegend
PerkinElmer has signed a cash and stock deal worth around $5.25 billion to acquire BioLegend, a California-based antibodies and reagents manufacturer. BioLegend caters to academic ... Read More
PerkinElmer to acquire TB test kit maker Oxford Immunotec for $591m
US medical diagnostic firm PerkinElmer has agreed to acquire Oxford Immunotec Global, a UK-based diagnostics company, for $22 per share or around $591 million. Oxford ... Read More
PerkinElmer to acquire cell engineering company Horizon Discovery
US-based PerkinElmer will acquire UK-based cell engineering company Horizon Discovery Group for nearly $383 million in an all-cash deal. The transaction, which is subject to ... Read More